FGF1 couples collagen secretion and trafficking to drive osteogenic differentiation

Area of Science:

• Biochemistry
• Cell Biology
• Orthopedics

Background:

• Osteoblast differentiation is vital for bone development and homeostasis.
• Dysregulation of osteogenesis causes bone defects and impairs skeletal integrity.
• Identifying osteogenic regulators is key for orthopedic regenerative medicine.

Purpose of the Study:

• To investigate the role of Fibroblast growth factor 1 (FGF1) in osteoblast differentiation.
• To elucidate the mechanisms by which FGF1 influences osteogenesis.
• To identify FGF1-related pathways as potential therapeutic targets for bone disorders.

Main Methods:

• MC3T3-E1 preosteoblast cell line was used.
• FGF1 knockdown and supplementation experiments were performed.
• Osteogenic differentiation markers (ALP activity, Runx2, SP7, COL1A1) and collagen trafficking were assessed.

Main Results:

• FGF1 knockdown impaired preosteoblast proliferation and osteogenic differentiation.
• Reduced ALP activity and downregulation of key osteogenic genes (Runx2, SP7, COL1A1) were observed upon FGF1 knockdown.
• FGF1 loss disrupted intracellular collagen trafficking and secretion, affecting matrix mineralization.

Conclusions:

• FGF1 is a critical regulator of osteogenesis, promoting osteoblast differentiation and proliferation.
• FGF1 facilitates type I collagen synthesis and secretion, contributing to matrix mineralization.
• FGF1-related pathways represent promising therapeutic targets for treating bone disorders.